Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 131 - 140 of 177

Selected Filters:
1 February 2021

MTN-025

Archived from the MTN website before it was taken down. Primary Objectives Characterize the safety profile associated with the open-label use of the dapivirine (25 mg) vaginal matrix ring (VR) in women Characterize adherence to the open-label use of the dapivirine VR (25 mg) in women Study Summary MTN-025, the HIV Open-label Prevention Extension (HOPE)…

Research

1 November 2020

Creating Demand for PrEP Among Adolescent Girls & Young Women

Slide-deck Review of HIV, PrEP and Contraceptive Focused Projects in Sub-Saharan Africa

Demand Creation/Marketing

Document
15 September 2020

Plan 4 PrEP: Étape 5: Évaluation de l’état de Préparation des Installations

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction de la PrEP…

Community/Advocacy, Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Service Delivery, Supply Chain Management

Document
15 September 2020

Plan 4 PrEP: Étape 3: Scénarios de Déploiement

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction et le déploiement…

Research, Normative Guidance/Policies, Service Delivery

Document
15 September 2020

Plan 4 PrEP: Étape 2: Paysage du Projet de la PrEP Orale

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction et le déploiement…

Research, Service Delivery

Document
15 September 2020

Plan 4 PrEP: Étape 4: Évaluation de la préparation

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction de la PrEP…

Community/Advocacy, Demand Creation/Marketing

Document
8 September 2020

Prevention Market Manager Project Summary

The Prevention Market Manager (PMM) is a collaboration between AVAC and the Clinton Health Access Initiative, funded by the Bill & Melinda Gates Foundation. This summary document provides a brief overview of PMM's goals, accomplishments, and learnings.

Research, Service Delivery

Document
16 July 2020

South African Guidelines for the Provision of Pre-exposure Prophylaxis (PrEP) to Persons at Substantial Risk of HIV Infection

These guidelines were developed by the South African National Department of Health and focus on the provision of PrEP as a part of a comprehensive approach to combination prevention, drawing on implementation and research evidence and WHO recommendations.

Normative Guidance/Policies

Document
23 June 2020

Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products.

Research

Document
23 June 2020

What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPTs)

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products. TRIO identified anticipated enablers and barriers to adoption…

Research

Document